For: | Li H, Wang JJ, Zhang M, Ren B, Li JX, Xu L, Wu H. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection. World J Gastrointest Oncol 2020; 12(4): 467-482 [PMID: 32368324 DOI: 10.4251/wjgo.v12.i4.467] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v12/i4/467.htm |
Number | Citing Articles |
1 |
Xiulan Peng, Xia Wang, Li Hua, Rui Yang, Daniele Maria-Ferreira. Prognostic and Clinical Value of the Systemic Immune-Inflammation Index in Biliary Tract Cancer: A Meta-Analysis. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/6988489
|
2 |
Yinghao Lv, Hu Liu, Penghui He, Sinan Xie, Xiuchun Yin, Yunshi Cai, Hong Wu. A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-45056-9
|
3 |
Guan Huang, Haofeng Zhang, Zhenwei Yang, Qingshan Li, Hao Yuan, Pengyu Chen, Chenxi Xie, Bo Meng, Xianzhou Zhang, Kunlun Chen, Haibo Yu. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-023-03281-6
|
4 |
Haofeng Zhang, Guan Huang, Qingshan Li, Yanbo Wang, Zhenwei Yang, Pengyu Chen, Hao Yuan, Kunlun Chen, Bo Meng, Haibo Yu. Construction and validation of a novel tumor morphology immune inflammatory nutritional score (TIIN score) for intrahepatic cholangiocarcinoma: a multicenter study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12375-7
|
5 |
Wen Li, Guangzhi Ma, Yunfu Deng, Wenjie Chen, Zhenkun Liu, Fang Chen, Qiang Wu. Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.570208
|
6 |
Ya-Ping Xu, Ze-Ning Dong, Si-Wei Wang, Yi-Min Zheng, Chi Zhang, Ying-Qun Zhou, Yu-Jie Zhao, Yan Zhao, Feng Wang, Rui Peng, Mao-Chun Tang, Dou-sheng Bai, Xiao-Yong Huang, Chuan-Yong Guo. circHMGCS1–016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-02095-2
|
7 |
Junya Toyoda, Kota Sahara, Shishir K. Maithel, Daniel E. Abbott, George A. Poultsides, Christopher Wolfgang, Ryan C. Fields, Jin He, Charles Scoggins, Kamran Idrees, Perry Shen, Itaru Endo, Timothy M. Pawlik. Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium. Annals of Surgical Oncology 2022; 29(12): 7605 doi: 10.1245/s10434-022-12058-2
|
8 |
Li-Ming Deng, Yi Wang, Jin-Huan Yang, Jia-Liang Li, Zi-Yan Chen, Wen-Ming Bao, Kai-Yu Chen, Xin-Fei Yao, Chong-Ming Zheng, Jiu-Yi Zheng, Zheng-Ping Yu, Bin Jin, Gang Chen. Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection. World Journal of Gastrointestinal Oncology 2021; 13(8): 929-942 doi: 10.4251/wjgo.v13.i8.929
|
9 |
Hui Li, Rongqiang Liu, Jiawang Li, Jiaxin Li, Hong Wu, Genshu Wang, Zhenhua Li, Dewei Li. Prognostic significance of gamma‐glutamyl transpeptidase to albumin ratio in patients with intrahepatic cholangiocarcinoma after hepatectomy. Journal of Cellular and Molecular Medicine 2022; 26(11): 3196 doi: 10.1111/jcmm.17321
|
10 |
Buwen Zhang, Weiyun Yao. Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02783-z
|
11 |
Xue-chun Liu, Yue-ping Jiang, Xue-guo Sun, Jian-jian Zhao, Ling-yun Zhang, Xue Jing. Prognostic Significance of the Systemic Immune-Inflammation Index in Patients With Cholangiocarcinoma: A Meta-Analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.938549
|
12 |
Haofeng Zhang, Qingshan Li, Guan Huang, Zhenwei Yang, Kunlun Chen, Bo Meng, Haibo Yu. Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index and albumin-bilirubin: a multicenter study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1239375
|
13 |
Lei Chen, Lei Chen, Ying-ying Wang, Li-xiang Zhang, Xiao-gang Xia. A predictive model of bowel resection for incarcerated inguinal hernia based on the systemic immune-inflammation index. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.990481
|
14 |
Jinyu Li, Long Gao, Tianci Liu, Duiping Feng. Association of systemic inflammation index with survival in patients with advanced perihilar cholangiocarcinoma treated with interventional therapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1038759
|